Navigation Links
ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
Date:11/12/2008

ocolitis caused by Staphylococcus aureus, including methicillin-resistant strains, and Cinryze(TM) (C1 inhibitor (human)) for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE), also known as C1 inhibitor deficiency (for prescribing information on ViroPharma's commercial products, please download the package inserts at http://www.viropharma.com/Products.aspx). ViroPharma currently focuses its drug development activities in diseases including cytomegalovirus (CMV), HAE and C. difficile.

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, http://www.viropharma.com. The company encourages investors to consult these sections for more information on ViroPharma and our business.

Forward-Looking Statements

Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide the Company's current expectations or forecasts of future events. Forward-looking statements in this press release include statements regarding ViroPharma's clinical development programs. Our actual results could differ materially from those results expressed in, or implied by, these forward-looking statements. The development and commercialization of pharmaceutical products is subject to risks and uncertainties. The data that were presented at the ACAAI Annual Meeting regarding the in the ongoing open-label study of Cinryze for acute treatment of HAE is partial data from an ongoing open label study. There can be no assurance that the complete data from this study will demonstrate that Cinryze successfully treats all types of acute hereditary angioedema (HAE) attacks and may not be predictive
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
2. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
3. ViroPharma Announces Discontinuation of HCV-796 Development
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. ViroPharma to Present at the Natixis Bleichroeder Conference
7. ViroPharma to Present at Three Upcoming Healthcare Conferences
8. Alba Therapeutics Announces Enrollment of Its First European Patient in Global Phase IIb Study of Larazotide Acetate for Treatment of Active Celiac Disease
9. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
10. Anesiva Announces Adlea ACTIVE-1 Phase 3 Clinical Results, Ceasing of Zingo Commercial Operations and Restructuring
11. Diagenic Announces Launch of First Breast Cancer Gene-Expression Blood Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014  Lpath, Inc. (NASDAQ: LPTN ... announced today that it has entered into definitive ... stock and 3,605,042 unregistered warrants in a registered ... registered share of common stock and one unregistered ... stock will be $3.475.  The warrants have an ...
(Date:9/19/2014)... ORLANDO, Fla. , Sept. 19, 2014  The ... grow, with the publication of two papers this past ... Otolaryngology – Head and Neck Surgery , finds ... objective and subjective measures of sleep disordered breathing, leading ... the reduction in obstructive sleep apnea severity and improvement ...
(Date:9/19/2014)... , Sept. 19, 2014  Over 200 runners participated ... to Benefit the Radiation Oncology Institute (ROI), hosted by ... Golden Gate Park in San Francisco.  ... , CEO of Radiation Business Solutions, "but at ... raised over $70,000 for the ROI this year. This ...
Breaking Medicine Technology:Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 2New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 3New Data shows Reductions in obstructive sleep apnea (OSA) severity and improvement of quality of life with Inspire therapy 4Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3
(Date:9/20/2014)... (PRWEB) September 20, 2014 Traditionally dentists have ... of South Charlotte Dentistry is re-visiting that advice ... the effects that coffee and wine have on oral health. ... studies determined that coffee may be beneficial in protecting against ... , The study on coffee was from the ...
(Date:9/20/2014)... Earlier this week, Home Depot revealed that up to ... card information pilfered by hackers, surpassing the 40 million Target ... articles like this one published by Bloomberg on September ... , “Most people tend to focus on how many credit ... score a game,” says Joe Caruso, founder and CEO/CTO of ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 The Arizona ... College (MCC) is celebrating National Manufacturing Day by opening ... enhanced machining, processing and additive manufacturing labs will be ... 3, 2014 at MCC’s Southern and Dobson campus (1833 ... in southeast Lot D. , The AzAMI at MCC ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 The children ... the balanced and active play they need. An empty ... Center - Lakeview Campus was transformed into a kid-designed ... of 150+ volunteers from Branches (@BranchesFL), ESPN (@TeamESPN), Disney ... , KaBOOM! believes a playground is more than a ...
(Date:9/19/2014)... PA (PRWEB) September 19, 2014 Are ... tissue because of problems with seasonal allergies or sinus ... a much better alternative. , She conceived of ... with having a runny nose in public. Since it ... it promotes more sanitary conditions, particularly when cooking or ...
Breaking Medicine News(10 mins):Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 2Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 3Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 4Health News:Don’t Let Data Breach Fatigue Cause Dangerous Cyber Security Complacency 5Health News:National Manufacturing Day Open House at Mesa Community College Oct. 3 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 3Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 4Health News:Nasal Drip Eliminator Invented by InventHelp Client (LCC-218) 2
... relatively novel technique for pain relief has been developed ... which holds a lot of promise// in alleviating extreme ... Para Vertebral Neurolytic block, which is a concoction of ... when injected into the para vertebral space. This works ...
... a test that they say can detect the deadly ... exist, but they are expensive// and time-consuming. Time is ... 24 hours. ,Professor Peter Seeberger and his ... antibodies against the anthrax surface molecule. They then attached ...
... Asia and Pacific will be promoted by the Asian Development Bank ... ADB report released on Friday. ,The ADB will conduct ... grant of $1 million, to address a broad range of growing ... Asia's energy consumption taking a heavy toll on the environment, ADB ...
... giants, Coke and Pepsi have challenged on Friday the ban ... drinks// , in separate petitions before the Kerala High Court. ... states had imposed a limited restriction on the sales of ... New Delhi, The Centre for Science and Environment (CSE), which ...
... US has ruled on Thursday that tobacco companies could no ... judge though did rule in their favour by giving the ... of any costly quitting programmes. , ,US District ... industry had 'marketed and sold their lethal product with zeal, ...
... of incomplete vaccination on the poultry flocks could be the ... ,Scientists at the Universities of Edinburgh and Warwick have ... of spreading of the deadly strains of bird flu like ... The researchers have explained in their study that has been ...
Cached Medicine News:Health News:Complete Vaccination Of Poultry Flock Essential to Check The Spread Of Avian Flu 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: